Harvard Bioscience, Inc.
NASDAQHarvard Bioscience heads into next week's earnings call with one genuinely interesting story playing out beneath the surface: insiders stepped in to buy their own stock six weeks ago, the stock has since rallied hard, and short sellers have scrambled back in — all ahead of a Q1 print now rescheduled for May 12. The insider activity is worth dwelling on. In mid-March, with the stock…
Snapshot as of 10 May 2026
Harvard Bioscience heads into next week's earnings call with one genuinely interesting story playing out beneath the surface: insiders stepped in to buy their own stock six weeks ago, the stock has since rallied hard,…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for HBIO — free to start on ORTEX.
Sign up for free →Open HBIO on ORTEX